The University of Queensland congratulates ResApp Health Limited (ASX:RAP) following the company’s success at the global Talent Unleashed Awards in Sydney.
The company, which is developing a smartphone medical application for the diagnosis and management of respiratory disease, won the global Best Tech IPO/Venture Capital Raising Category, having won the same category at the Award’s Asia Pacific ceremony in Melbourne in July 2016.
The Award finalists were judged by a panel led by Apple co-founder Steve Wozniak.
ResApp was established in 2014 based on technology developed by UQ’s Associate Professor Udantha Abeyratne from the Faculty of Engineering, Architecture and Information Technology.
The award follows the company’s announcement that it is planning a clinical study at Massachusetts General Hospital (MGH) a 1,000-bed academic medical centre in Boston (US).
Dr Dean Moss, chief executive of UQ’s main commercialisation company UniQuest said he was delighted to see ResApp’s success recognised on the world stage.
“We are very proud of the success the company has achieved to date and will continue to watch their progress with great interest,” Dr Moss said.
Since listing on the Australian Stock Exchange in mid-2015, the company has raised more than $16 million.